搜尋結果
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 5 小時前, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in ...
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
Reuters· 11 小時前Israel-based Teva Pharmaceuticals , and French partner Medincell said on Wednesday their ...
We're exiting a troubled drugmaker and putting the cash into 2 health-care stocks with ...
CNBC· 3 小時前Following the trades, Jim Cramer's Charitable Trust will own 895 shares of ABT, increasing ...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 1 日前, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the < ...
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Reuters· 2 日前Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday ...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters· 7 小時前Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now ...
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 6 日前Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology ...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 6 日前, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 7 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 5 日前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...